PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 25, 2024Annals of Surgery21 citations

Somatostatin Versus Octreotide for Prevention of Postoperative Pancreatic Fistula: The PREFIPS Randomized Clinical Trial

View Full Paper
SGSébastien GaujouxJRJean-Marc RégimbeauGPGuillaume Piessen

Key Points

Key points are not available for this paper at this time.

Abstract

Pharmacological prevention of postoperative pancreatic fistula (POPF) after pancreatectomy is open to debate. The present study compares clinically significant POPF rates in patients randomized between somatostatin versus octreotide as prophylactic treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gaujoux et al. (2024) studied this question.

synapsesocial.com/papers/68e6d7feb6db643587655417https://doi.org/10.1097/sla.0000000000006313
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Classification of Surgical Complications2004 · 31,452 citations
  2. 2Should all pancreatic surgery be centralized regardless of patients' comorbidity?2019 · 40 citations
  3. 3Stump closure reinforcement with absorbable fibrin collagen sealant sponge (TachoSil) does not prevent pancreatic fistula after distal pancreatectomy: the FIABLE multicenter controlled randomized study2015 · 73 citations
  4. 4Effect of Hydrocortisone vs Pasireotide on Pancreatic Surgery Complications in Patients With High Risk of Pancreatic Fistula2020 · 64 citations
  5. 5Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? – A systematic review with meta-analysis of randomized-controlled trials2020 · 42 citations